APA (7th ed.) Citation

M, A., J, L., AL, B., U, M., M, B., M, M., . . . F, C. (2025). Tau levels in platelets isolated from Huntington's disease patients serve as a biomarker of disease severity. Journal of neurology, 272(3), 254. https://doi.org/10.1007/s00415-025-12966-9

Chicago Style (17th ed.) Citation

M, Alpaugh, et al. "Tau Levels in Platelets Isolated from Huntington's Disease Patients Serve as a Biomarker of Disease Severity." Journal of Neurology 272, no. 3 (2025): 254. https://doi.org/10.1007/s00415-025-12966-9.

MLA (9th ed.) Citation

M, Alpaugh, et al. "Tau Levels in Platelets Isolated from Huntington's Disease Patients Serve as a Biomarker of Disease Severity." Journal of Neurology, vol. 272, no. 3, 2025, p. 254, https://doi.org/10.1007/s00415-025-12966-9.